Literature DB >> 22943581

Are serum and urine neutrophil gelatinase-associated lipocalin predictive of renal graft function in short term?

Nahid Rahimzadeh1, Hasan Otukesh, Rozita Hoseini, Hadi Sorkhi, Morvarid Otukesh, Sara Hoseini, Mina Torkzaban.   

Abstract

NGAL is a member of the lipocalin protein family that has diverse function but similar structure. The functions of NGAL are not clear, but it appears to be expressed in stress conditions and in tissues undergoing involution. Varied studies have shown increased levels of plasma or urinary NGAL in diverse renal damages. The aim of this study was the serial measurement of serum and urinary NGAL within the first week after renal transplantation in children to predict immediate and short-term graft function. A total of 27 patients were assessed. These patients were classified into those with rapid reduction in serum creatinine (more than 50% reduction in serum creatinine in the first day after transplantation) and patients with slow reduction in serum creatinine (<50% reduction in serum creatinine). We also assessed the absolute reduction in serum creatinine before and after transplantation. Serum and urinary NGAL on the first day post-transplantation were higher in recipients with slow reduction in serum creatinine (urinary NGAL at the first day: 197 ± 153 [s.e.m.] vs. 22.54 ± 8.5 [s.e.m.], p = 0.04; serum NGAL at the first day: 199 vs. 69.8, p = 0.003). The cutoff point of serum NGAL at the first day after transplantation for prediction of slow creatinine reduction was 174 ng/mL with a sensitivity of 100% and specificity of 95.5%. However, we did not find association between the absolute reduction in serum creatinine before and after transplantation with the amount of serum and urinary NGAL post-transplant. Additionally, we did not find any effect of high serum and urine NGAL concentration on the graft function at the first year post-transplant. Although it is supposed that high serum and urine NGAL may predict ischemia of graft in early phases; however, it appears that this mild ischemic injury to graft without DGF or SGF cannot affect the graft function in short-term period. Further studies are needed using larger transplant recipients in pediatric age group. It is also needed to determine the effects of mild ischemic injuries on the graft function in long-term period in future studies.
© 2012 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22943581     DOI: 10.1111/j.1399-3046.2012.01770.x

Source DB:  PubMed          Journal:  Pediatr Transplant        ISSN: 1397-3142


  10 in total

Review 1.  Role for urinary biomarkers in diagnosis of acute rejection in the transplanted kidney.

Authors:  Basma Merhi; George Bayliss; Reginald Y Gohh
Journal:  World J Transplant       Date:  2015-12-24

Review 2.  Novel bone metabolism-associated hormones: the importance of the pre-analytical phase for understanding their physiological roles.

Authors:  Giovanni Lombardi; Mosè Barbaro; Massimo Locatelli; Giuseppe Banfi
Journal:  Endocrine       Date:  2017-02-08       Impact factor: 3.633

3.  Effect of continuous renal replacement therapy on kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin in patients with septic acute kidney injury.

Authors:  Yiming Shao; Yinqiang Fan; Yuliu Xie; Lu Yin; Yuanli Zhang; Liehua Deng; Xiaocong Sun; Xin Shao; Xinzhang Tan; Junbing He; Shiman Zhao
Journal:  Exp Ther Med       Date:  2017-05-05       Impact factor: 2.447

Review 4.  The Most Promising Biomarkers of Allogeneic Kidney Transplant Rejection.

Authors:  Karolina Rogulska; Iwona Wojciechowska-Koszko; Barbara Dołęgowska; Ewa Kwiatkowska; Paulina Roszkowska; Patrycja Kapczuk; Danuta Kosik-Bogacka
Journal:  J Immunol Res       Date:  2022-05-28       Impact factor: 4.493

Review 5.  Neutrophil gelatinase-associated lipocalin as a biomarker of acute kidney injury: a critical evaluation of current status.

Authors:  Anja Haase-Fielitz; Michael Haase; Prasad Devarajan
Journal:  Ann Clin Biochem       Date:  2014-02-11       Impact factor: 2.057

6.  Detection of early renal injury in children with solid tumors undergoing chemotherapy by urinary neutrophil gelatinase-associated lipocalin.

Authors:  Mohamed A Almalky; Sheriefa A Hasan; Tamer H Hassan; Doaa A Shahbah; Mohamed A Arafa; Naglaa A Khalifa; Rasha E Ibrahim
Journal:  Mol Clin Oncol       Date:  2015-08-31

7.  Use of Basiliximab with the Standard Immunosuppressive Protocol in Pediatric Renal Transplantation: A Double-Blind Randomized Clinical Trial.

Authors:  M Shemshadi; R Hoseini; R Zareh; H Otukesh
Journal:  Int J Organ Transplant Med       Date:  2020

8.  Neutrophil Gelatinase Associated Lipocalin Is an Early and Accurate Biomarker of Graft Function and Tissue Regeneration in Kidney Transplantation from Extended Criteria Donors.

Authors:  Vincenzo Cantaluppi; Sergio Dellepiane; Michela Tamagnone; Davide Medica; Federico Figliolini; Maria Messina; Ana Maria Manzione; Massimo Gai; Giuliana Tognarelli; Andrea Ranghino; Caterina Dolla; Silvia Ferrario; Ciro Tetta; Giuseppe Paolo Segoloni; Giovanni Camussi; Luigi Biancone
Journal:  PLoS One       Date:  2015-06-30       Impact factor: 3.240

9.  Plasma Neutrophil Gelatinase-Associated Lipocalin as a Marker for Prediction of 3-Month Graft Survival after Kidney Transplantation.

Authors:  A Jafari; M R Khatami; S Dashti-Khavidaki; M Lessan-Pezeshki; A Abdollahi
Journal:  Int J Organ Transplant Med       Date:  2017-02-01

Review 10.  Neutrophil Gelatinase-Associated Lipocalin as a Biomarker of Allograft Function After Renal Transplantation: Evaluation of the Current Status and Future Insights.

Authors:  Maria Cappuccilli; Irene Capelli; Giorgia Comai; Giuseppe Cianciolo; Gaetano La Manna
Journal:  Artif Organs       Date:  2017-12-20       Impact factor: 3.094

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.